Pneumology
PRINCIPAL INVESTIGATORS
- Eva Farrero Muñoz
- Rosa Maria Lopez Lisbona
- Jesus Ribas Sola
- Ana Cordoba Izquierdo
- Vanesa Vicens Zygmunt
- Noelia Cubero Frutos
- Mariana Mercedes Muñoz Esquerre
- Maria Dela Salud Santos Perez
- Antonio Rosell Gratacos
CLINICAL RESEARCHERS
- Carmen Monasterio Ponsa
- Roger Llatjos Sanuy
- Marta Lopez Sanchez
- Neus Salord Oleo
- Susana Padrones Sanchez
- Enric Prats Soro
- Rosa Planas Balague
POSTDOCTORAL RESEARCHERS (R2)
- Guillermo Rafael Suarez Cuartin
PREDOCTORAL RESEARCHERS (R1)
- Carlos Esteban Machahua Huamani
- Merce Gasa Galmes
- Samantha Aso Gonzalez
- Ester Cuevas Sales
- Lurdes Planas Cerezales
- Guadalupe Bermudo Peloche
SCIENTIFIC SUPPORT
- Montserrat Navarro Rodriguez
- Maria Jose Rodriguez Lopez
- Yasmina Guerrero Martinez
MANAGEMENT SUPPORT
- Jessica Germaine Shull
Translational Medicine
Cardiovascular, Respiratory and Systemic Diseases and cellular aging
Scientific production
37
PAPERS
10 PUBLICATIONS IN FIRST DECILE
18 PUBLICATIONS IN FIRST QUARTILE
Selected publications
- Planas-Cerezales L, Arias-Salgado EG, Buendia-Roldán I, Montes-Worboys A, López CE, Vicens-Zygmunt V, Hernaiz PL, Sanuy RL, Leiro-Fernandez V, Vilarnau EB, Llinás ES, Sargatal JD, Abellón RP, Selman M, Molina-Molina M . Predictive factors and prognostic effect of telomere shortening in pulmonary fibrosis.. RESPIROLOGY. 10.1111/resp.13423
- Sellarés J., Molina-Molina M.. Serum Biomarkers in Diffuse Interstitial Lung Diseases [Biomarcadores séricos en las enfermedades pulmonares intersticiales difusas]. ARCHIVOS DE BRONCONEUMOLOGIA. 10.1016/j.arbres.2019.08.002
- Molina-Molina M.. The Future of Pharmacological Treatment in Idiopathic Pulmonary Fibrosis [Futuro del tratamiento farmacológico en fibrosis pulmonar idiopática]. ARCHIVOS DE BRONCONEUMOLOGIA. 10.1016/j.arbres.2019.05.008
- Careta, Oriol; Cuevas, Ester; Munoz-Esquerre, Mariana; Lopez-Sanchez, Marta; Pascual-Gonzalez, Yuliana; Dorca, Jordi; Aliagas, Elisabet; Santos, Salud;. Imbalance in the Expression of Genes Associated with Purinergic Signalling in the Lung and Systemic Arteries of COPD Patients. SCI. REP.. 10.1038/s41598-019-39233-y
- Gasa M, López-Padrós C, Monasterio C, Salord N, Mayos M, Vilarrasa N, Fernandez-Aranda F, Montserrat JM, Dorca J . Anthropometrical phenotypes are important when explaining obstructive sleep apnea in female bariatric cohorts.. JOURNAL OF SLEEP RESEARCH. 10.1111/jsr.12830
Research highlights
PROJECTS
2 Ongoing projects
1 Ongoing project
24 Ongoing clinical trials
6 Started clinical trials
PUBLISHED WORKS
1 Thesis
INNOVATION
1 Patent
1 license
1 spin-off
Selected projects
- Caracterización de la fibrosis pulmonar telomérica y su regulación biológica (1/1/2019 – 31/12/2021) PI: MOLINA MOLINA, MARIA. Funder: FIS-Instituto de Salud Carlos III.
- Mediadores implicados en el remodelado vascular pulmonar y sistémico de pacientes con EPOC y en un modelo experimental de enfisema (1/1/2017 – 31/12/2019) PI: SANTOS PEREZ, MARIA SALUD. Funder: FIS-Instituto de Salud Carlos III.
- A phase 3, randomized, double-blind, parallel-group, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of GLPG1690 in addition to local standard of care for minimum 52 weeks in subjects with idiopathic pulmonary fibrosis (18/1/2019 – 18/1/2020) PI: MOLINA MOLINA, MARIA. Funder ref.: GLPG1690-CL-303.
- Qualification of imaging methods to asses cancer drug induced interstitial lung disease (15/1/2019 – ) PI: ASO GONZALEZ, SAMANTHA. Funder ref.: 1658-IG.
- A phase 2b, randommized, double blind, placebo-controlled, dose ranging, multi-center study to evaluate the efficacy and safety of GB001 as maintenance therapy in adult subjects with moderate to severe asthma (6/2/2019 – ) PI: MUñOZ ESQUERRE, MARIANA. Funder ref.: GB001-2001.
- Ensayo de extensión abierto de seguridad a largo plazo de Nintedanib en pacientes con enfermedad pulmonar intersticial fibrosante progresiva (EPI-FP) (6/3/2019 – 6/3/2025) PI: MOLINA MOLINA, MARIA. Funder ref.: 1199-0248.
- Effects of oral Levosimendan (odm-109) on respiratory function in patients with als: open-label extension for patients completing study 3119002 (7/5/2019 – ) PI: FARRERO MUÑOZ, EVA.